Skip to main content
Top
Published in: Journal of Ovarian Research 1/2013

Open Access 01-12-2013 | Research

Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary

Authors: Takashi Yamada, Takayoshi Kanda, Hiroshi Mori, Kaname Shimokawa, Mitsuo Kagawa, Yuro Shibayama

Published in: Journal of Ovarian Research | Issue 1/2013

Login to get access

Abstract

Background

Cell lines are very useful for clinical and basic research. Thus far, only 11 reports have documented the characteristics of ovarian endometrioid adenocarcinoma cell lines in the literature. Due to the scarcity of information, the establishment of an ovarian malignant tumor cell line with distinctive characteristics is particularly important to study this disease. Thus, this study was undertaken to establish and characterize a new human endometrioid adenocarcinoma cell line of the ovary.

Methods

The cell line NOMH-1 was established from an ovarian tumor of a 44-year-old woman. Features of the cell line studied included morphology, chromosome analysis, heterotransplantation, tumor markers, and chemosensitivity.

Results

This cell line has been growing well for 232 months and subcultured more than 50 times. Monolayer cultured cells were polygonal in shape, showing a pavement-like arrangement and a tendency to stack without contact inhibition. They exhibited a human karyotype with a modal chromosomal number in the hypertriploid range. The cells could be transplanted into the subcutis of nude mice and produced tumors resembling the original tumor. NOMH-1 cells expressed both CEA and CA19-9 which were identified immunohistochemically in the original tumor and the heterotransplanted tumor. The cells were sensitive to paclitaxel, an agent commonly used in the treatment of gynecological cancers.

Conclusions

NOMH-1 is the first ovarian endometrioid adenocarcinoma cell line in which CEA and CA19-9 expression have been defined. This newly established cell line should be useful for investigating the characteristics of ovarian endometrioid adenocarcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, Campbell IG: Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996, 56: 3534–3539.PubMed Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, Campbell IG: Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996, 56: 3534–3539.PubMed
2.
go back to reference Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000, 60: 7052–7056.PubMed Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000, 60: 7052–7056.PubMed
3.
go back to reference Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH: Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004, 94: 456–462. 10.1016/j.ygyno.2004.05.006PubMedCrossRef Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH: Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004, 94: 456–462. 10.1016/j.ygyno.2004.05.006PubMedCrossRef
4.
go back to reference Papanicolaou GN: A new procedure for staining vaginal smears. Science 1942, 95: 438–439. 10.1126/science.95.2469.438PubMedCrossRef Papanicolaou GN: A new procedure for staining vaginal smears. Science 1942, 95: 438–439. 10.1126/science.95.2469.438PubMedCrossRef
5.
go back to reference Masuda H, Fujihira S, Ueno H, Kagawa M, Katsuoka Y, Mori H: Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Med Electron Microsc 2003, 36: 183–191. 10.1007/s00795-003-0213-4PubMedCrossRef Masuda H, Fujihira S, Ueno H, Kagawa M, Katsuoka Y, Mori H: Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Med Electron Microsc 2003, 36: 183–191. 10.1007/s00795-003-0213-4PubMedCrossRef
6.
go back to reference Tamura T, Sasaki Y, Nishiwaki Y, Saijo N: Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities. Jpn J Cancer Res 1995, 86: 1203–1209. 10.1111/j.1349-7006.1995.tb03316.xPubMedCrossRef Tamura T, Sasaki Y, Nishiwaki Y, Saijo N: Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities. Jpn J Cancer Res 1995, 86: 1203–1209. 10.1111/j.1349-7006.1995.tb03316.xPubMedCrossRef
7.
go back to reference Taguchi T, Wakui A, Hasegawa K, Niitani H, Furue H, Ohta K, Hattori T: Phase I clinical study of CPT-11. Research group of CPT-11. Gan To Kagaku Ryoho 1990, 17: 115–120.PubMed Taguchi T, Wakui A, Hasegawa K, Niitani H, Furue H, Ohta K, Hattori T: Phase I clinical study of CPT-11. Research group of CPT-11. Gan To Kagaku Ryoho 1990, 17: 115–120.PubMed
8.
go back to reference Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O: Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991, 40: 118–128. 10.1016/0090-8258(91)90102-BPubMedCrossRef Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O: Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991, 40: 118–128. 10.1016/0090-8258(91)90102-BPubMedCrossRef
9.
go back to reference Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987, 56: 279–285. 10.1038/bjc.1987.190PubMedCentralPubMedCrossRef Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987, 56: 279–285. 10.1038/bjc.1987.190PubMedCentralPubMedCrossRef
10.
go back to reference Freedman RS, Pihl E, Kusyk C, Gallager HS, Rutledge F: Characterization of an ovarian carcinoma cell line. Cancer 1978, 42: 2352–2359. 10.1002/1097-0142(197811)42:5<2352::AID-CNCR2820420536>3.0.CO;2-#PubMedCrossRef Freedman RS, Pihl E, Kusyk C, Gallager HS, Rutledge F: Characterization of an ovarian carcinoma cell line. Cancer 1978, 42: 2352–2359. 10.1002/1097-0142(197811)42:5<2352::AID-CNCR2820420536>3.0.CO;2-#PubMedCrossRef
11.
go back to reference Nagai S, Nozawa S, Kurihara S, Mukai M: Cytologic and biologic studies of endometrioid carcinoma of the ovary. Acta Cytol 1983, 27: 676–682.PubMed Nagai S, Nozawa S, Kurihara S, Mukai M: Cytologic and biologic studies of endometrioid carcinoma of the ovary. Acta Cytol 1983, 27: 676–682.PubMed
12.
go back to reference Uehara S, Soh K, Hoshiai H, Yajima A, Suzuki M, Abe H: Establishment and characterization of human ovarian endometrioid carcinoma cell line. Nihon Sanka Fujinka Gakkai Zasshi 1983, 35: 19–26.PubMed Uehara S, Soh K, Hoshiai H, Yajima A, Suzuki M, Abe H: Establishment and characterization of human ovarian endometrioid carcinoma cell line. Nihon Sanka Fujinka Gakkai Zasshi 1983, 35: 19–26.PubMed
13.
go back to reference Ishiwata I, Ishiwata C, Soma M, Ishikawa H: Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component). Gynecol Oncol 1986, 25: 95–107. 10.1016/0090-8258(86)90070-3PubMedCrossRef Ishiwata I, Ishiwata C, Soma M, Ishikawa H: Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component). Gynecol Oncol 1986, 25: 95–107. 10.1016/0090-8258(86)90070-3PubMedCrossRef
14.
go back to reference Fujii T: Establishment and characterization of human ovarian endometrioid carcinoma cell line. Nihon Sanka Fujinka Gakkai Zasshi 1989, 41: 161–166.PubMed Fujii T: Establishment and characterization of human ovarian endometrioid carcinoma cell line. Nihon Sanka Fujinka Gakkai Zasshi 1989, 41: 161–166.PubMed
15.
go back to reference van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI: Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer 1993, 53: 613–620. 10.1002/ijc.2910530415PubMedCrossRef van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI: Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer 1993, 53: 613–620. 10.1002/ijc.2910530415PubMedCrossRef
16.
go back to reference Hirte HW, Kaiser JS, Bacchetti S: Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer 1994, 74: 900–906. 10.1002/1097-0142(19940801)74:3<900::AID-CNCR2820740317>3.0.CO;2-NPubMedCrossRef Hirte HW, Kaiser JS, Bacchetti S: Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer 1994, 74: 900–906. 10.1002/1097-0142(19940801)74:3<900::AID-CNCR2820740317>3.0.CO;2-NPubMedCrossRef
17.
go back to reference Yuan Y, Kim WH, Han HS, Lee JH, Park HS, Chung JK, Kang SB, Park JG: Establishment and characterization of human ovarian carcinoma cell lines. Gynecol Oncol 1997, 66: 378–387. 10.1006/gyno.1997.4785PubMedCrossRef Yuan Y, Kim WH, Han HS, Lee JH, Park HS, Chung JK, Kang SB, Park JG: Establishment and characterization of human ovarian carcinoma cell lines. Gynecol Oncol 1997, 66: 378–387. 10.1006/gyno.1997.4785PubMedCrossRef
18.
go back to reference Umezu T, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A, Kikkawa F: Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity. Hum Cell 2007, 20: 71–76. 10.1111/j.1749-0774.2007.00030.xPubMedCrossRef Umezu T, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A, Kikkawa F: Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity. Hum Cell 2007, 20: 71–76. 10.1111/j.1749-0774.2007.00030.xPubMedCrossRef
19.
go back to reference Matsumoto K, Katsumata N, Yamanaka Y, Yonemori K, Kohno T, Shimizu C, Andoh M, Fujiwara Y: The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer. Gynecol Oncol 2006, 100: 412–416. 10.1016/j.ygyno.2005.10.013PubMedCrossRef Matsumoto K, Katsumata N, Yamanaka Y, Yonemori K, Kohno T, Shimizu C, Andoh M, Fujiwara Y: The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer. Gynecol Oncol 2006, 100: 412–416. 10.1016/j.ygyno.2005.10.013PubMedCrossRef
Metadata
Title
Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary
Authors
Takashi Yamada
Takayoshi Kanda
Hiroshi Mori
Kaname Shimokawa
Mitsuo Kagawa
Yuro Shibayama
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2013
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/1757-2215-6-8

Other articles of this Issue 1/2013

Journal of Ovarian Research 1/2013 Go to the issue